Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease
- PMID: 34973870
- DOI: 10.1016/j.clon.2021.12.013
Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease
Comment in
-
In Reply to Onal et al.Clin Oncol (R Coll Radiol). 2022 Apr;34(4):e173. doi: 10.1016/j.clon.2022.01.009. Epub 2022 Jan 31. Clin Oncol (R Coll Radiol). 2022. PMID: 35093250 No abstract available.
Comment on
-
Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease.Clin Oncol (R Coll Radiol). 2022 Jan;34(1):63-69. doi: 10.1016/j.clon.2021.10.004. Epub 2021 Oct 29. Clin Oncol (R Coll Radiol). 2022. PMID: 34756755
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical